GENE ONLINE|News &
Opinion
Blog

Deals
IPO BeiGene
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Deals Parkinson’s Disease
Novartis, UCB Take Aim at Parkinson’s Disease Under $1.65 Billion Collab
2021-12-03
Regulatory T-cell Therapy
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
Asia-Pacific AAV Gene Therapy
Astellas Taps Dyno in $1.6+ Billion Deal to Develop AAV Gene Therapies
2021-12-02
Technology Agriculture
Aanika Bioscience Raises Fresh Capital to Scale Its Microbial “Tags” Technology Platform
2021-12-01
China Radiopharmaceutical
Ablaze Pharma Launches with $75 Million to Bring Targeted Radiotherapies into China
2021-12-01
Asia-Pacific Samsung Biologics
Samsung Biologics Strikes Deal with GreenLight Bio to Manufacture mRNA Vaccines
2021-11-29
M&A Equity Stake
Roche Gets Shareholders Nod to Repurchase $21B Equity Stake Held By Novartis
2021-11-27
Licensing Cancer Vaccine
In a Blockbuster Day, Vaccibody Gets New Name and a Multi-Program Regeneron Deal to Boot
2021-11-24
Licensing mRNA Technology
Sanofi Bets on Baidu’s Algorithm to Develop mRNA-Based Therapeutics
2021-11-23
Funding Cell Therapy
Taiwan’s Acepodia Closes $100 Million Series C to Accelerate Cancer Assets
2021-11-22
M&A RNA Therapeutics
Following Two Years of Promising RNAi Collab, Novo Nordisk Decides to Acquire Dicerna for $3.3 Billion
2021-11-18
Funding Gene Editing
Chroma Medicine Debuts with High Hopes for “Game-Changing” Epigenetic Genome Editors
2021-11-17
Funding Autoimmune Disease
With New Funding, ACELYRIN Licenses First Therapeutic and Leaps into Late-Stage Trials for Autoimmune Diseases
2021-11-17
Funding Immunotherapy
Boston-Based Cancer Immunotherapy Startup Secures $45 Million in Series B
2021-11-15
1 … 25 26 27 28 29 … 47
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top